97 related articles for article (PubMed ID: 22475924)
1. Percutaneous biopsy based on PET/CT findings in cancer patients: technique, indications, and results.
Bitencourt AG; Tyng CJ; Pinto PN; Almeida MF; Meyrellis LC; Pinheiro RP; Lima EN; Chojniak R
Clin Nucl Med; 2012 May; 37(5):e95-7. PubMed ID: 22475924
[TBL] [Abstract][Full Text] [Related]
2. Metabolic PET/CT-guided lung lesion biopsies: impact on diagnostic accuracy and rate of sampling error.
Guralnik L; Rozenberg R; Frenkel A; Israel O; Keidar Z
J Nucl Med; 2015 Apr; 56(4):518-22. PubMed ID: 25698780
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT-directed biopsy: does it offer incremental benefit?
Purandare NC; Kulkarni AV; Kulkarni SS; Roy D; Agrawal A; Shah S; Rangarajan V
Nucl Med Commun; 2013 Mar; 34(3):203-10. PubMed ID: 23353885
[TBL] [Abstract][Full Text] [Related]
5. Imaging-guided biopsy of (18)F-FDG-avid extrapulmonary lesions: do lesion location and morphologic features on CT affect the positive predictive value for malignancy?
Nguyen ML; Gervais DA; Blake MA; Mueller PR; Sahani DV; Hahn PF; Uppot RN
AJR Am J Roentgenol; 2013 Aug; 201(2):433-8. PubMed ID: 23883226
[TBL] [Abstract][Full Text] [Related]
6. Minimal invasive biopsy of intraconal expansion by PET/CT/MRI image-guided navigation: a new method.
Reinbacher KE; Pau M; Wallner J; Zemann W; Klein A; Gstettner C; Aigner RM; Feichtinger M
J Craniomaxillofac Surg; 2014 Oct; 42(7):1184-9. PubMed ID: 24726395
[TBL] [Abstract][Full Text] [Related]
7. Comparison of CT-guided percutaneous biopsy with and without registration of prior PET/CT images to diagnose mediastinal tumors.
Yokoyama K; Ikeda O; Kawanaka K; Nakasone Y; Tamura Y; Inoue S; Sakamoto F; Yoshida M; Shiraishi S; Yamashita Y
Cardiovasc Intervent Radiol; 2014 Oct; 37(5):1306-11. PubMed ID: 24263776
[TBL] [Abstract][Full Text] [Related]
8. Advantages of percutaneous abdominal biopsy under PET-CT/ultrasound fusion imaging guidance: a pictorial essay.
Paparo F; Piccazzo R; Cevasco L; Piccardo A; Pinna F; Belli F; Bacigalupo L; Biscaldi E; De Caro G; Rollandi GA
Abdom Imaging; 2014 Oct; 39(5):1102-13. PubMed ID: 24777592
[TBL] [Abstract][Full Text] [Related]
9. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
Kawata S; Imaizumi M; Kako Y; Oku N
Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
[TBL] [Abstract][Full Text] [Related]
11. [Percutaneous CT-guided cutting needle biopsy of pulmonary lesions: retrospective analysis of 153 procedures].
Besa C; Huele A; Bächler P; Cruz F
Rev Med Chil; 2013 Apr; 141(4):449-56. PubMed ID: 23900365
[TBL] [Abstract][Full Text] [Related]
12. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
13. Multi-bed-position acquisition technique for deep inspiration breath-hold PET/CT: a preliminary result for pulmonary lesions.
Daisaki H; Shinohara H; Terauchi T; Murano T; Shimada N; Moriyama N; Tateishi U
Ann Nucl Med; 2010 Apr; 24(3):179-88. PubMed ID: 20084475
[TBL] [Abstract][Full Text] [Related]
14. Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma.
Kim YI; Cheon GJ; Paeng JC; Cho JY; Kang KW; Chung JK; Kim EE; Lee DS
Nucl Med Commun; 2014 Jun; 35(6):606-12. PubMed ID: 24598843
[TBL] [Abstract][Full Text] [Related]
15. CT-guided percutaneous core needle biopsy in oncology outpatients: sensitivity, specificity, complications.
Steil S; Zerwas S; Moos G; Bittinger F; Hansen T; Mergenthaler U; Weide R
Onkologie; 2009 May; 32(5):254-8. PubMed ID: 19420971
[TBL] [Abstract][Full Text] [Related]
16. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
Cerci JJ; Tabacchi E; Bogoni M
PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
[TBL] [Abstract][Full Text] [Related]
17. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
18. Does the pretreatment tumor sampling location correspond with metabolic activity on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy?
Koolen BB; Elshof LE; Loo CE; Wesseling J; Vrancken Peeters MJ; Vogel WV; Rutgers EJ; Valdés Olmos RA
Eur J Radiol; 2013 Dec; 82(12):2353-8. PubMed ID: 23998705
[TBL] [Abstract][Full Text] [Related]
19. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
Xu R; Kido S; Suga K; Hirano Y; Tachibana R; Muramatsu K; Chagawa K; Tanaka S
Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
[TBL] [Abstract][Full Text] [Related]
20. The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients.
Cerci JJ; Pereira Neto CC; Krauzer C; Sakamoto DG; Vitola JV
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):98-103. PubMed ID: 23100050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
